The metabolic syndrome: in need of a global mission statement

被引:34
作者
Cameron, A. J. [1 ]
Zimmet, P. Z. [1 ]
Shaw, J. E. [1 ]
Alberti, K. G. M. M. [2 ]
机构
[1] Newcastle Univ, Baker IDI Heart & Diabet Inst, Dept Epidemiol & Clin Diabet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[2] Newcastle Univ, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
关键词
metabolic syndrome; obesity; risk prediction; CORONARY-HEART-DISEASE; FRAMINGHAM RISK SCORE; CARDIOVASCULAR-DISEASE; PREDICTION; MORTALITY; IDENTIFICATION; OBESITY; TIME; TOOL;
D O I
10.1111/j.1464-5491.2009.02681.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The value of clinical definitions of the metabolic syndrome has been questioned, with confusion surrounding their intended use and purpose. Our aim was to construct a mission statement that outlines the value of the metabolic syndrome in clinical and public health settings. Case studies have been used to demonstrate three key points. We argue here for recognition of obesity as being a crucial element within the metabolic syndrome but perhaps even more important before its development. We also contend that the concept does indeed have a role as a risk prediction tool, and that it could provide a useful metric for the scale and progress of the looming global epidemic of diabetes and cardiovascular disease. Through appreciation of its purpose, and recognition of both its limitations and those attributes that make it unique and valuable, we believe we have demonstrated here that the metabolic syndrome deserves its place in the global toolbox of diabetes and CVD prevention.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 24 条
  • [1] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [2] [Anonymous], RISK ASS TOOL EST 10
  • [3] Coronary artery disease - Framingham risk score and prediction of coronary heart disease death in young men
    Berry, Jarett D.
    Lloyd-Jones, Donald M.
    Garside, Daniel B.
    Greenland, Philip
    [J]. AMERICAN HEART JOURNAL, 2007, 154 (01) : 80 - 86
  • [4] The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study
    Cameron, A. J.
    Magliano, D. J.
    Zimmet, P. Z.
    Welborn, T. A.
    Colagiuri, S.
    Tonkin, A. M.
    Shaw, J. E.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2008, 264 (02) : 177 - 186
  • [5] Central Obesity as a Precursor to the Metabolic Syndrome in the AusDiab Study and Mauritius
    Cameron, Adrian J.
    Boyko, Edward J.
    Sicree, Richard A.
    Zimmet, Paul Z.
    Soderberg, Stefan
    Alberti, K. George M. M.
    Tuomilehto, Jaakko
    Chitson, Pierrot
    Shaw, Jonathan E.
    [J]. OBESITY, 2008, 16 (12) : 2707 - 2716
  • [6] Abdominal obesity and metabolic syndrome
    Despres, Jean-Pierre
    Lemieux, Isabelle
    [J]. NATURE, 2006, 444 (7121) : 881 - 887
  • [7] Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence
    Ford, ES
    [J]. DIABETES CARE, 2005, 28 (07) : 1769 - 1778
  • [8] Critical questions about the metabolic syndrome
    Greenland, P
    [J]. CIRCULATION, 2005, 112 (24) : 3675 - 3676
  • [9] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy, SM
    Cleeman, JI
    Daniels, SR
    Donato, KA
    Eckel, RH
    Franklin, BA
    Gordon, DJ
    Krauss, RM
    Savage, PJ
    Smith, SC
    Spertus, JA
    Costa, F
    [J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752
  • [10] *INT DIAB FED, 2006, DIAB ATL